Document is current

Any future updates will be listed below

Valencene as a novel potential downregulator of THRB in NSCLC: network pharmacology, molecular docking, molecular dynamics simulation, ADMET analysis, and in vitro analysis

Crossref DOI link: https://doi.org/10.1007/s11030-024-11008-2

Published Online: 2024-10-19

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark